NHS Genomic Medicine Service - Most Suitable Provider Process

Location

Leeds

Description

This is a notice of intention to make an award in respect of the NHS Genomic Medicine Service pursuant to the Most Suitable Provider (MSP) Process for the NHS Genomic Medicine Service (NHS GMS). For the avoidance of doubt, this is an intention to award notice. A notice of the confirmation of the award of each contract will be issued once they are signed.Pursuant to the NHS GMS contracts, provider are to provide the following functions: • Organisational leadership, governance and partnership arrangements;• Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);• Laboratory operating model;• Clinical function: cancer genomics;• Clinical function: rare disease;• Clinical function: population health;• Promotion of and supporting and leading where relevant science, research and / or innovation;• Transformation and Service Improvement;• People – workforce, education and training; and• Data and digital Pursuant to the NHS GMS contracts, providers are to provide the following functions:* Organisational leadership, governance and partnership arrangements;* Delivery of genomic testing outlined in the National Genomic Test Directory (NGTD);* Laboratory operating model;* Clinical function: cancer genomics;* Clinical function: rare disease;* Clinical function: population health;* Promotion of and supporting and leading where relevant science, research and / or innovation;* Transformation and Service Improvement;* People – workforce, education and training; and* Data and digitalThe Commissioner intends to award contracts following the Most Suitable Process to 7 providers which are existing providers. This is an expansion of existing services which, under PSR, constitutes a new service.The approximate lifetime value of the contract for all Lots is £5,175,000,000.The services will start on 1st April 2026 and the initial period will run until 31st March 3034 with an option to extend for up to a further 2 years (of 2 x 12 month periods).Please note that the figure included in the 'Awarded Value' section of this part of the notice is the total approximate lifetime value of all Lots of the NHS Genomic Medicine Service contract. For the avoidance of doubt, this is not the approximate lifetime value for each Lot. The approximate lifetime value for each Lot shall be included within the confirmation of contract award notice (which shall be issued once contracts have been signed).

Lot Division

Award Detail

Award Criteria

CPV Codes

• 85100000 - Health services

Indicators

• Options are available.
• Award on basis of price and quality.

Legal Justification

This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.

Other Information

This is a Provider Selection Regime (PSR) intention to award notice. This intention to award notice is subject to Regulation 10(7) of the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Procurement Act Regulations 2023 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Tuesday 4th November 2025. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR.Written representations should be sent to england.genomics@nhs.net, ensuring the following details are referenced:Project reference: C368833Project title: NHS Genomic Medicine Service - Most Suitable Provider processThis decision has been made as per NHS England governance processes, by the Commercial Executive Group on 14th October 2025 and the National Commissioning Group on 21st October 2025. No conflicts of Interest were identified amongst decision-makers.Each of the 5 key criteria were balanced with equal priority and considered on this basis and consideration was given to the basic selection criteria. Following provider assessments, it was agreed that the providers are the only providers capable of meeting the service specifications and requirements of the NHS GMS in full.Additional CPV codes include:85145000-7 (Services provided by medical laboratories),85148000-8 (Medical analysis services)85111810-1 (Blood analysis services)85121200-5 (Medical specialist services)85140000-2 (Miscellaneous health services)